Zymevolver® Biosynthetic Technology Platform
Shenzhen Hygieia Biotech Co., Ltd. (hereinafter referred to as "Hygieia") established its own Zymevolver ® strain construction and enzyme engineering evolution platform to carry out R&D, production and sales of pharmaceutical and dietary supplement raw materials. In the existing enzyme library, the types and numbers of biological enzymes can cover the conventional biocatalytic reaction routes，The team is skilled in building cell factory with E. coli and yeast as the chassis and applying them to the biosynthesis of multiple scenarios. Hygieia Biotech’s Biosynthetic Technology Platform involves Fermentation Engineering, Enzyme Engineering, Bioreaction Engineering, Separation Engineering, Chemical Synthesis, etc.
6 advantages of Hygieia’ Biosynthetic Technology Platform
Hygieia Biotech’s Biosynthetic Technology Platform offers a unique set of advantages:
Extensive Enzyme Armory: With nearly 500 enzymes available, it provides a diverse range for various applications.
Biological Enzyme Mutants: Through high-throughput screening and enzyme immobilization, it enables fine-tuning and optimization.
Efficient Project Completion: Using a systematic enzyme evolution and transformation process, projects can be completed in just 3 to 6 months.
Industrialization Capability: It seamlessly scales from Gram and Kilogram development to mass production, including large-scale fermentation and post-treatment preparation.
Protein Evolution Platform: This platform handles projects from small molecule synthesis to large molecule development.
Customized CDMO Services: It caters to diverse industries like agriculture, feed production, and diagnostic reagents with tailored enzyme solutions.
Key Ingredients from Enzyme Armory of Zymevolver® Biosynthetic Technology Platform
The Zymevolver® Biosynthetic Technology Platform harnesses a wealth of key ingredients from its extensive enzyme database to drive innovation and production. Among these ingredients are the likes of Nicotinamide Mononucleotide (NMN), Glutathione, Phosphatidylserine (PS), Proteinase K, Sitagliptin, Ursodeoxycholic acid, Lipoic Acid, Stevioside, Psicose, and more. This diverse selection represents the building blocks for a wide range of applications, from pharmaceuticals and biofuels to food and cosmetics. Zymevolver’s rich enzyme database ensures a versatile and robust platform for the development of cutting-edge solutions across multiple industries.
Hygieia has been rated as Synthetic Biology Enterprises, Professional, Fine, Special and New Enterprises in Shenzhen, Innovative Enterprise, Technology Enterprise; Participate in 3 group standard, 2 soft works, 3 authorized invention patents, A number of invention patent examination stage.
Hygieia has actively participated in the research projects of domestic and foreign research institutions, and has published a number of application literature reports on new products with Huazhong University of Science and Technology, Mosi Biotech and other domestic and foreign research institutions, providing more basic research data support for the industrial chain.